Back to News
Market Impact: 0.15

3 AI Infrastructure Stocks That Could Double by 2027

AMD
CRWV
GETY
IUSDF
META
NFLX
NVDA
Artificial IntelligenceTechnology & InnovationCompany FundamentalsAnalyst InsightsCorporate Earnings

The article highlights continued momentum in AI infrastructure demand, citing Nvidia’s fiscal Q1 2027 revenue +85% y/y and profit +211% y/y, with the stock up ~1,700% since its 2022 low and trading at a P/E of 31 vs. the S&P 500 average of 32. CoreWeave is described as higher-risk but potentially undervalued, with Q1 2026 revenue +112% and backlog rising to over $99B, despite a ~50% drawdown from its high and P/S around 7. Meta is positioned as scaling AI infrastructure via $125B–$145B capex, alongside Q1 2026 revenue +33%, net income +61%, and a P/E of 24, though 2026 revenue growth is forecast to slow to +26%.

Analysis

The market is still pricing AI as if every layer of the stack can compound at the same rate, but that’s unlikely. The cleaner winner is the vendor with pricing power and ecosystem lock-in: demand can soften at the margin and NVDA still captures the highest dollar content per deployed GPU, which matters more than unit growth once hyperscalers start optimizing capex. The weak link is the leveraged middleware/hosting layer; if large customers increasingly internalize compute, the spread between top-line growth and free cash flow can gap wide for neocloud names.

META is interesting because it is not just a user of AI capex, it can become a capital allocator that arbitrages the market for compute. That creates a second-order pressure on third-party providers like CRWV: even if total AI spend rises, some of it gets pulled back in-house, which can compress neocloud multiples before revenue growth slows. Over 1-3 months, the catalyst path is less about revenue and more about whether capex guidance is treated as strategic investment or as an efficiency drag; if investors stop penalizing the spend, META re-rates faster than the market expects.

The contrarian view is that the market may be over-fixated on headline growth and underweighting balance-sheet and financing risk. CRWV’s backlog is only valuable if it converts with acceptable customer concentration, utilization, and debt service; any delay in deployment or refinancing premium would hit equity far harder than the article implies. For NVDA, the key falsifier is not slower growth alone but evidence of mix deterioration, tighter export constraints, or a step-down in attach rates across the ecosystem; absent that, the stock can remain expensive in absolute terms while still cheap versus its own growth rate.